Hindsight rather than foresight: reality versus the EU draft guideline on pharmaceuticals in the environment.
The strategy of passing much of European Union (EU) waste water through a sewage treatment plant (STP) before discharging it into rivers or lakes has done much to improve the quality of our inland waterways. But we still face a very worrying situation. Environmental problems have surfaced in conjunction with the STPs and their effluent recipients, and attention has turned to human pharmaceuticals and endocrine active substances, in particular, as another source of potential pollutants. Trying to assess the detrimental effects of these chemicals on the aquatic environment represents an extreme cost in terms of animals, time and finance. Instead, it would be better to go back to basics and to prevent entry of these substances into our aquatic environment.
O'Brien
Evelyn
E
Environmental Toxicology, University of Konstanz, Konstanz, D-78457, Germany. evelyn.obrien@uni-konstanz.de
Dietrich
Daniel R
DR
D064420:Drug-Related Side Effects and Adverse Reactions; D004784:Environmental Monitoring / Q000331:legislation & jurisprudence / Q000379:methods* / Q000592:standards; D005062:European Union; D017408:Guidelines as Topic; D007220:Industrial Waste / Q000331:legislation & jurisprudence / Q000517:prevention & control*; D004364:Pharmaceutical Preparations / Q000032:analysis*; D018570:Risk Assessment / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards; D014877:Water Pollution, Chemical / Q000331:legislation & jurisprudence / Q000517:prevention & control*; D018508:Water Purification / Q000379:methods* / Q000592:standards*
D007220:Industrial Waste; D004364:Pharmaceutical Preparations